Unicycive Therapeutics, Inc. (UNCY) SEC filings

UNCY SEC filings moved a median of +2.77% by the close. UNCY SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the UNCY overview →

27 measured UNCY SEC filing events.

Where these UNCY SEC filings landedvs 26 measured UNCY SEC filing reactions
UNCY SEC filingMiddle 50% · -1.97% to +5.95%Zero: 0.00%Median: +2.77%Median +2.77%-8.00%0+8.00%
Middle 50% of UNCY SEC filing reactions-1.97% to +5.95%
Median reaction (to close)+2.77%
Measured reactions26
Point-in-time · zero look-ahead

Half of the 26 UNCY SEC filing events with a measured close landed between -1.97% and +5.95%; 62% closed up.

DateHeadlineEvent5-minTo close
Form 8-K Unicycive Therapeutics, For: Sep 28SEC filing · Form 8-K-5.95%-2.36%
Form 8-K Unicycive Therapeutics, For: Sep 03SEC filing · Form 8-K-5.95%-2.36%
Form 10-Q Unicycive Therapeutics, For: Jun 30SEC filing · Form 10-Q+0.97%+4.86%
Form 8-K Unicycive Therapeutics, For: Aug 12SEC filing · Form 8-K+0.97%+4.86%
Form 8-K Unicycive Therapeutics, For: Jul 02SEC filing · Form 8-K-1.27%+3.62%
Form 8-K Unicycive Therapeutics, For: Jun 19SEC filing · Form 8-K+8.67%+12.91%
Form DEFA14A Unicycive Therapeutics,SEC filing · Form DEFA14A+8.67%+12.91%
Form EFFECT Unicycive Therapeutics,SEC filing · Form EFFECT+2.11%+0.70%
Form 8-K Unicycive Therapeutics, For: Jun 05SEC filing · Form 8-K-1.21%-4.86%
Form S-3 Unicycive Therapeutics,SEC filing · Form S-3-1.21%-4.86%
Form 10-Q Unicycive Therapeutics, For: Mar 31SEC filing · Form 10-Q+0.63%+2.77%
Form 8-K Unicycive Therapeutics, For: May 12SEC filing · Form 8-K+0.63%+2.77%
Form S-8 Unicycive Therapeutics,SEC filing · Form S-8-3.00%-0.61%
Form ARS Unicycive Therapeutics, For: Dec 31SEC filing · Form ARS+1.80%+5.95%
Form DEF 14A Unicycive Therapeutics, For: Jun 19SEC filing · Form DEF+1.80%+5.95%
Form DEFA14A Unicycive Therapeutics,SEC filing · Form DEFA14A+1.80%+5.95%
Form 8-K Unicycive Therapeutics, For: Apr 06SEC filing · Form 8-K+2.88%-4.75%
Form 10-K Unicycive Therapeutics, For: Dec 31SEC filing · Form 10-K+0.65%-0.81%
Form 8-K Unicycive Therapeutics, For: Mar 30SEC filing · Form 8-K+0.65%-0.81%
Form 8-K Unicycive Therapeutics, For: Nov 14SEC filing · Form 8-K+0.41%+1.58%
Form 10-Q Unicycive Therapeutics, For: Sep 30SEC filing · Form 10-Q+1.58%+7.08%
Form 8-K Unicycive Therapeutics, For: Nov 12SEC filing · Form 8-K+1.58%+7.08%
Form 8-K Unicycive Therapeutics, For: Oct 28SEC filing · Form 8-K-0.77%-9.23%
Form 8-K Unicycive Therapeutics, For: Aug 15SEC filing · Form 8-K-1.29%—
Form 8-K Unicycive Therapeutics, For: Aug 15SEC filing · Form 8-K-6.68%-14.82%
Form 10-Q Unicycive Therapeutics, For: Jun 30SEC filing · Form 10-Q+1.50%+9.20%
Form 8-K Unicycive Therapeutics, For: Aug 14SEC filing · Form 8-K+1.50%+9.20%
That’s how UNCY usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More UNCY: earnings → · analyst actions → · UNCY overview →